We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CENT icon
1301
Central Garden & Pet Co
CENT
$2.78B
$76.6K ﹤0.01%
2,101
+395
+23% +$15.2K
LBRDA icon
1302
Liberty Broadband Class A
LBRDA
$4.72B
$76.1K ﹤0.01%
990
+533
+117% +$32.5K
EVX icon
1303
VanEck Environmental Services ETF
EVX
$100M
$74K ﹤0.01%
2,050
GDXJ icon
1304
VanEck Junior Gold Miners ETF
GDXJ
$6.99B
$71.7K ﹤0.01%
1,468
RSPD icon
1305
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$321M
$70.3K ﹤0.01%
1,350
LPL icon
1306
LG Display
LPL
$2.93B
$69.9K ﹤0.01%
17,268
+2,338
+16% +$9.68K
UIS icon
1307
Unisys
UIS
$250M
$68.4K ﹤0.01%
+12,035
New +$59.6K
PACK icon
1308
Ranpak Holdings
PACK
$550M
$67K ﹤0.01%
+10,254
New +$70.6K
JBLU icon
1309
JetBlue
JBLU
$2.23B
$65.8K ﹤0.01%
+10,026
New +$56.5K
ESGE icon
1310
iShares ESG Aware MSCI EM ETF
ESGE
$6.41B
$64.8K ﹤0.01%
1,779
HRTX icon
1311
Heron Therapeutics
HRTX
$92M
$63.5K ﹤0.01%
31,903
+10,578
+50% +$25.3K
IVOV icon
1312
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.36B
$62.2K ﹤0.01%
650
LLYVK icon
1313
Liberty Live Group Series C
LLYVK
$9.45B
$61.4K ﹤0.01%
1,197
-56
-4% -$2.24K
ICL icon
1314
ICL Group
ICL
$6.76B
$61.1K ﹤0.01%
14,368
+4,140
+40% +$17.5K
JEPI icon
1315
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
$56.5K ﹤0.01%
950
DHS icon
1316
WisdomTree US High Dividend Fund
DHS
$1.59B
$56.3K ﹤0.01%
+600
New +$54.1K
PAVE icon
1317
Global X US Infrastructure Development ETF
PAVE
$14.1B
$53.5K ﹤0.01%
1,300
ESGU icon
1318
iShares ESG Aware MSCI USA ETF
ESGU
$17.8B
$53.2K ﹤0.01%
422
GRAB icon
1319
Grab
GRAB
$14.1B
$52.7K ﹤0.01%
+13,875
New +$47.3K
SCHA icon
1320
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$50.9K ﹤0.01%
1,976
CGEN icon
1321
Compugen
CGEN
$214M
$49.8K ﹤0.01%
27,500
PICK icon
1322
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.18B
$48.8K ﹤0.01%
1,129
VTWO icon
1323
Vanguard Russell 2000 ETF
VTWO
$17.5B
$48.7K ﹤0.01%
545
XT icon
1324
iShares Future Exponential Technologies ETF
XT
$3.77B
$47.3K ﹤0.01%
777
ABR icon
1325
Arbor Realty Trust
ABR
$979M
$43.8K ﹤0.01%
2,818
+701
+33% +$9.74K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.